New Delhi: Prime Minister Narendra Modi on Thursday directed health authorities to scale up COVID-19 testing and sero-surveys as he called for continued vigilance and a high state of preparedness against the virus. He said regular and speedy testing at a low cost must be available to all at the earliest.Also Read - Infected With Omicron? List of Foods Covid Patients Must Eat While Recovering
The PM, while chairing a review meeting of the research and vaccine deployment ecosystem against the coronavirus pandemic, also underscored the need for continuous and rigorous scientific testing and validation of traditional medicine treatments. Also Read - Stunning Pictures From Narmada Ghats Where Sara Ali Khan-Vicky Kaushal Are Currently Shooting
He appreciated the efforts of Ministry of AYUSH for conducting evidence-based research and providing reliable solutions in this difficult time, an official statement from PMO said. Also Read - Indonesia Travel Update: Indonesia Reopens For Singapore Travellers to Boost Tourism
“The Prime Minister reiterated the the country’s resolve to provide cost-effective, easily available and scalable solutions for testing, vaccine and medication, not only for India but for the entire world,” it said.
At the meeting, also attended by Union Health Minister Harsh Vardhan, NITI Aayog Member (Health), Principal Scientific Advisor, senior scientists and other officials, Modi called for continued vigilance and a high state of preparedness against the pandemic.
Modi also appreciated efforts made by Indian vaccine developers and manufacturers to rise to the COVID-19 challenge and committed to continue government facilitation and support for all such efforts.
The prime minister said regulatory reform is a dynamic process and experts in every current and emerging domain should be used by the regulator proactively, as many new approaches have emerged.
He also took stock of the Health Ministry’s comprehensive distribution and delivery mechanism for vaccines, including mechanisms for adequate procurement, and technologies for bulk-stockpiling, filling vials for distribution and ensuring effective delivery.
According to the statement, the prime minister directed that both sero-surveys and testing must be scaled up and he said that the facility to get tested regularly, speedily and inexpensively must be available to all at the earliest.
India’s COVID-19 tally of cases climbed to 73.07 lakh on Thursday with 67,708 new cases in the last 24 hours, while 63,83,441 people have recuperated so far pushing the national recovery rate to 87.35 per cent, according to the Union Health Ministry data.
The death toll has climbed to 1,11,266 with the novel coronavirus virus claiming 680 lives in a span of 24 hours in the country, the data updated at 8 am showed.
The COVID-19 case fatality rate has, however, further declined to 1.52 per cent.
There are 812390 active cases of coronavirus infection in the country which comprises 11.11 per cent of the total caseload.
According to the ICMR, a cumulative total of 9,12,26,305 samples have been tested up to October 14 with 11,36,183 samples being tested on Wednesday.
(With inputs from PTI)